Take a look back at the week's top stories.
In this first edition of the e-book, AUGS present a comprehensive review of the mechanistic insights centered around the priorities identified during a “think tank” brainstorming session. The overarching goal of the e-book is to synthesize and interpret the available mechanistic data and to build a shared disease model of 2 PFDs—POP and SUI—that will serve to (1) further our understanding of the pathogenesis of these PFDs, (2) recognize important knowledge gaps and pinpoint research priorities, (3) identify novel targets for interventions, and (4) facilitate economically viable cross-disciplinary research initiatives.
A consensus-based document establishing clear terminology for cosmetic gynecology procedures has been created.
Marco Taglietti, MD, president and CEO of Scynexis, sits with Contemporary OB/GYN® to discuss the recent approval of ibrexafungerp (Brexafemme) for the reduction in incidence of recurrent vulvovaginal candidiasis.
This article aims to present consensus recommendations for the optimal perioperative management of patients undergoing urogynecological surgery.
David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter, sits down with Contemporary OB/GYN® to give a full recap of where restrictions on reproductive rights have been and where they're going.
The patient-focused book from entitled Pelvic Floor Health: Your Guide to Pregnancy and Postpartum Care is now available in paperback and e-book!
Test your knowledge with diagnosing Tiny Tim.
In this document, AUGS describes how the task force was organized and conducted the work to develop strategies focused on DEI.
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
December 5th 2023Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
Integrating pharmacists into PPHTN management for enhanced blood pressure control
December 4th 2023A study reveals that involving pharmacists in the care of postpartum women at risk of persistently elevated blood pressure, as presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition, can provide an effective and feasible solution to managing hypertensive disorders, reducing postpartum readmission risks, and improving overall health care access.
Read More